Comparative Effectiveness of Naltrexone Formulations in Alcohol Use Disorder: An Updated Meta-Analysis. [PDF]
Nunez NA, Ali HM, Hassett L, Singh B.
europepmc +1 more source
Case report: Acamprosate for treatment of volatile hydrocarbon (VHC) inhalant use disorder with comorbid alcohol use disorder. [PDF]
Piri N, Campbell W.
europepmc +1 more source
Shared effects of the opioid antagonist naltrexone on first-hand and empathic pain. [PDF]
Braunstein JT, Rütgen M, Lamm C.
europepmc +1 more source
Pharmacotherapy for Alcohol Craving Reduction: Efficacy of Short-Term Treatments in Alcohol Use Disorder. [PDF]
Cheibub David Marin M +3 more
europepmc +1 more source
An Experimental Study to Evaluate the Role of Buprenorphine, Morphine, and Naltrexone in Animal Models of Depression. [PDF]
Suja Nongtdu NL, Verma V.
europepmc +1 more source
Limited but Growing Use of Medications for Alcohol Use Disorder by Gastroenterologists: A Medicare Analysis, 2016-2024. [PDF]
Huskamp HA +5 more
europepmc +1 more source
Pharmacists expand access to contingency management in patients with substance use disorders. [PDF]
Salsman M +5 more
europepmc +1 more source
Quantitative assessment of light discomfort thresholds in a patient with photoallodynia treated with topical naltrexone 0.01. [PDF]
Lixi F +7 more
europepmc +1 more source
The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV. [PDF]
Appa A +8 more
europepmc +1 more source
Samidorphan sadness: does the addition of samidorphan to olanzapine have prodepressive effects? [PDF]
Parkerson JA +3 more
europepmc +1 more source

